Neurogene Inc.NGNENASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | -100.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | -100.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | -918.88% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +52.71% | +15.84% | +24.21% | +24.28% | +24.86% |
| Weighted Average Shares Diluted Growth | +52.71% | +15.84% | +24.21% | +24.28% | +24.86% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +8.00% | +1.19% | +102.32% | +27.98% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +83.20% | +50.84% | +61.40% | +65.34% | +75.38% |
| Book Value per Share Growth | +19.60% | +44.03% | +37.56% | +41.84% | +54.76% |
| Debt Growth | +26.66% | -23.54% | -6.00% | -6.76% | -22.43% |
| R&D Expense Growth | +40.32% | +25.96% | +31.16% | +23.01% | +5.87% |
| SG&A Expenses Growth | +63.16% | +141.86% | +84.89% | +26.34% | +11.23% |